tiprankstipranks
Trending News
More News >
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market

Coya Therapeutics, Inc. (COYA) Financial Statements

Compare
110 Followers

Coya Therapeutics, Inc. Financial Overview

Coya Therapeutics, Inc.'s market cap is currently $97.30M. The company's EPS TTM is $-0.13; its P/E ratio is -4.22; Coya Therapeutics, Inc. is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 3.55M$ 6.00M$ 0.00$ 0.00$ 0.00
Gross Profit$ -8.31M$ 500.68K$ -4.41M$ 0.00$ 0.00
Operating Income$ -17.25M$ -7.90M$ -9.81M$ -4.87M$ -1.04M
EBITDA$ -17.20M$ -7.33M$ -9.26M$ -4.85M$ 0.00
Net Income$ -14.88M$ -7.99M$ -12.24M$ -4.89M$ -1.10M
Balance Sheet
Cash & Short-Term Investments$ 38.34M$ 32.63M$ 5.93M$ 4.34M$ 8.72M
Total Assets$ 44.35M$ 41.26M$ 8.40M$ 4.79M$ 8.75M
Total Debt$ 0.00$ 0.00$ 12.97M$ 0.00$ 0.00
Net Debt$ -38.34M$ -32.63M$ 7.03M$ -4.34M$ -8.72M
Total Liabilities$ 4.77M$ 5.63M$ 16.79M$ 1.15M$ 447.12K
Stockholders' Equity$ 39.58M$ 35.64M$ -8.39M$ 3.64M$ 8.30M
Cash Flow
Free Cash Flow$ -10.29M$ -11.19M$ -7.24M$ -4.04M$ -391.27K
Operating Cash Flow$ -10.29M$ -11.19M$ -7.24M$ -3.90M$ -391.27K
Investing Cash Flow$ -25.00K$ -543.19K$ -525.00K$ -136.80K$ 0.00
Financing Cash Flow$ 16.03M$ 38.43M$ 9.36M$ -340.58K$ 9.11M
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Coya Therapeutics, Inc. Debt to Assets

Coya Therapeutics, Inc. Cash Flow

Coya Therapeutics, Inc. Forecast EPS vs Actual EPS